Skip to main content

Agius, Rudi

Early Stimulated Immune Responses Predict Clinical Disease Severity in Hospitalized COVID-19 Patients

Svanberg, Rebecka
MacPherson, Cameron
Zucco, Adrian
Agius, Rudi
Faitova, Tereza
Andersen, Michael Asger
Da Cunha-Bang, Caspar
Gjærde, Lars Klingen
Møller, Maria Elizabeth Engel
Brooks, Patrick Terrence
Lindegaard, Birgitte
Sejdic, Adin
Gang, Anne Ortved
Hersby, Ditte Stampe
Brieghel, Christian
Nielsen, Susanne Dam
Podlekareva, Daria
Hald, Annemette
Bay, Jakob Thaning
Marquart, Hanne
Lundgren, Jens
Lebech, Anne-Mette
Helleberg, Marie
Niemann, Carsten Utoft
Ostrowski, Sisse Rye
Innate Immunity Viral Infection
The immune pathogenesis underlying the diverse clinical course of COVID-19 is poorly understood. Currently, there is an unmet need in daily clinical practice for early biomarkers and improved risk stratification tools to help identify and monitor COVID-19 patients at risk of severe disease.

Personalized Survival Probabilities for SARS-CoV-2 Positive Patients by Explainable Machine Learning

Zucco, Adrian G.
Agius, Rudi
Svanberg, Rebecka
Moestrup, Kasper S.
Marandi, Ramtin Z.
MacPherson, Cameron Ross
Lundgren, Jens
Ostrowski, Sisse R.
Niemann, Carsten U.
Machine Learning Prognosis Viral Infection
Interpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12~weeks of a first positive SARS-CoV-2 test. By leveraging data on 33,938 confirmed SARS-CoV-2 cases in eastern Denmark, we considered 2723 variables extracted from electronic health records (EHR) including demographics, diagnoses, medications, laboratory test results and vital parameters. A discrete-time framework for survival modelling enabled us to predict personalized survival curves and explain individual risk factors. Performance on the test set was measured with a weighted concordance index of 0.95 and an area under the curve for precision-recall of 0.71. Age, sex, number of medications, previous hospitalizations and lymphocyte counts were identified as top mortality risk factors. Our explainable survival model developed on EHR data also revealed temporal dynamics of the 22 selected risk factors. Upon further validation, this model may allow direct reporting of personalized survival probabilities in routine care.
Personalized Survival Probabilities for SARS-CoV-2 Positive Patients by Explainable Machine Learning